Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives

Coronavirus disease 2019 (COVID-19) is a potentially fatal disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that preferentially infects the respiratory tract. Bradykinin (BK) is a hypotensive substance that recently emerged as one of the mechanisms to explain COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Manuele Figueiredo, de Araújo-Júnior, João Xavier, da Silva-Júnior, Edeildo Ferreira, Heimfarth, Luana, Martins-Filho, Paulo Ricardo, Quintans, Jullyana de Souza Siqueira, Quintans-Júnior, Lucindo José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795307/
https://www.ncbi.nlm.nih.gov/pubmed/35089406
http://dx.doi.org/10.1007/s00210-022-02206-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795307/
https://www.ncbi.nlm.nih.gov/pubmed/35089406
http://dx.doi.org/10.1007/s00210-022-02206-6

Ejemplares similares